Health
European Union Intellectual Property Office Revokes Counterfeiter's Fake AQUAGOLD® Design Registration and Orders Payment to Aquavit of All Legal Fees and Costs
NEW YORK, Dec. 11, 2020 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") received a decision from the European Union Intellectual Property Office (EUIPO) today that it has revoked the counterfeiter U-BioMed's falsely registered AQUAGOLD® design, originally created and owned by Aquavit. ...
2020-12-11 03:10
3581
Global Biosimilars Market Poised to Grow at Chart-topping Levels with a CAGR of 17.3%, Reaching $79.2 Billion by 2026
With the third wave of biosimilars in the spotlight during the forecast period, revenues from the sensory organs market will dominate growth, finds Frost & Sullivan SANTA CLARA, Calif., Dec. 11, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Access to New Therapy Areas to Drive Major Gr...
2020-12-11 03:00
1845
DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor and positive impact of reference anti-HER2 treatment on overall survival
Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020...
2020-12-10 22:19
5008
INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China
PLYMOUTH MEETING, Pa. and SUZHOU, China, Dec. 10, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("...
2020-12-10 21:00
6234
MicroPort CRM initiates a clinical trial for breakthrough innovative left ventricular lead Axone(TM)
PARIS, Dec. 10, 2020 /PRNewswire/ -- MicroPort Cardio Rhythm Management (CRM) has announced the first enrollment in the Astral-4LV clinical trial[1] to evaluate the safety and efficiency of Axone™, a breakthrough innovative quadripolar left ventricular lead. Axone™ is designed for use in heart fa...
2020-12-10 19:23
1602
Chinese and European Media Carry Out Multilateral Cooperation to Achieve Win-Win Results
BEIJING, Dec. 10, 2020 /PRNewswire/ -- A statement on strengthening media cooperation issued by China Media Group (CMG) and its European media partners, calling on the Chinese and European media to fulfill their responsibilities as public information disseminators and jointly help the internat...
2020-12-10 17:30
1707
Cigna Study Shows Hong Kong's Overall Well-being Index Continues to Drop during the COVID-19 Pandemic
HONG KONG, Dec. 10, 2020 /PRNewswire/ -- Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's annual 360 Well-Being Survey, this research is the third in a series of studies to better understand the impact of...
2020-12-10 16:04
3063
ReCor Medical Announces Positive Results in RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise™ Ultrasound Renal Denervation System
PALO ALTO, Calif., Dec. 10, 2020 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise™ Ultrasound Renal Denervation System (the "Paradise System") demonstrated positive results in the RADIANCE-HTN TRIO ("TRIO") study...
2020-12-10 16:01
1715
InDevR Expands Commercial Portfolio for Coronavirus Vaccine Characterization
BOULDER, Colo., Dec. 10, 2020 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Spike Protein Kit and SARS-CoV-2 Spike ...
2020-12-10 15:00
1338
Nippon Express Korea Receives ISO 13485 Certification of Compliance with International Standard for Medical Device Quality Management Systems
TOKYO, Dec. 10, 2020 /PRNewswire/ -- Nippon Express Korea Co., Ltd. (hereinafter "NE Korea"), a local subsidiary of Nippon Express Co., Ltd., last month obtained ISO 13485 certification of compliance with the ISO standard for medical device quality management systems at its business location at I...
2020-12-10 15:00
1572
New Travel Health and Safety Protocols Implemented in Bali to Welcome Back Global Visitors
JAKARTA, Indonesia, Dec. 10, 2020 /PRNewswire/ -- Having seen an increase numbers of tourists, The Ministry of Tourism and Creative Economy (MoTCE) of Indonesia has made massive strides to ensure a safe Cleanliness, Health, Safety, and Environmental Sustainability (CHSE) protocols inBali. Namely ...
2020-12-10 13:56
46334
Bill and Melinda Gates call for collaboration, continued innovation to overcome challenges of delivering COVID-19 scientific breakthroughs to the world
Gates Foundation pledges additional $250 million to accelerate development and equitable distribution of COVID-19 tests, treatments, and vaccines to end the pandemic SEATTLE, Dec. 10, 2020 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced it will commit an additional$250 millio...
2020-12-10 13:01
2934
Kazia to Collaborate with Pacific Pediatric Neuro-Oncology Consortium (PNOC) for New Paxalisib Combination Study in DIPG
SYDNEY, Dec. 10, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a Letter of Intent with the Pacific Pediatric Neuro-Oncology Consortium (PNOC) to launch a clinical trial of...
2020-12-10 12:51
6789
Beijing Forum 2020 shines a spotlight on new challenges and opportunities of globalization
BEIJING, Dec. 10, 2020 /PRNewswire/ -- The Beijing Forum 2020 opened at Peking University onDecember 5, with bilingual live broadcasts across multiple platforms. This year, the international academic event, co-organized by Peking University, Beijing Municipal Education Commission, and Chey Instit...
2020-12-10 12:26
4851
Stellar Results from Kintor's GT90001 and Opdivo Combo Therapy in the Second-line Treatment of Advanced Liver Cancer: ORR Reached up to 40%
SHANGHAI, Dec. 10, 2020 /PRNewswire/ -- On December 9, 2020, Kintor Pharmaceutical Limited (HKEx: 9939) is pleased to announce that the Group has collected positive data in phase II clinical trials of combination therapy of ALK-1 (GT90001) antibody and PD-1 (Nivolumab or Opdivo) antibody for the ...
2020-12-10 12:14
3194
Cybernet on the Front Lines of Massive Vaccination Program
IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ -- All eyes are on the United Kingdom today as they are the first western country in the world to begin to issue COVID-19 vaccinations. This ambitious undertaking, which has been dubbed the largest mass-vaccination program in the country's history, will ...
2020-12-10 10:43
2157
Sports Taping by 3NS, a Korean Kinesiology Tape Producer, Landing in Germany
BERLIN, Germany, Dec. 10, 2020 /PRNewswire/ -- It is easy to see athletes taping their knees, thighs, ankles, and arms in various sports events such as marathon and basketball. The Kinesiology Tape has made steady progress since 1970 with the aim of preventing injuries and muscle pain to athletes...
2020-12-10 09:37
1656
3NS, a Korean Kinesiology Tape manufacturer, recommends effective use of sports tape
BERLIN, Germany, Dec. 10, 2020 /PRNewswire/ -- Kinesiology Tape, a sports product and medical device that can prevent injuries and relieve pain with simple use, is drawing attention these days when home training is happening more often during this Pandemic. The Kinesiology Tape, a flexible sport...
2020-12-10 09:36
1932
Ascentage Pharma Announces Updates on the Clinical Development of APG-2575, including an ORR of 70% in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
SUZHOU, China and ROCKVILLE, MD, Dec. 10, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced updates on the clinical devel...
2020-12-10 09:03
2699
CStone's Partner Blueprint Medicines Announces U.S. FDA Approval of GAVRETO (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
SUZHOU, China, Dec. 10, 2020 /PRNewswire/ -- The partner of CStone Pharmaceuticals ("CStone", HKEX: 2616), Blueprint Medicines, announced on December 1st that the U.S. Food and Drug Administration (FDA) has approved GAVRETO™ (pralsetinib) for the treatment of patients with RET-altered thyroid can...
2020-12-10 08:30
5177
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15
Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00
Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4434
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3617
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
3590
PAVS Achieves 18,037% YoY Revenue Increase in 2025 Interim Results
2025-12-05 21:45
3387